0001209191-16-109439.txt : 20160318
0001209191-16-109439.hdr.sgml : 20160318
20160318151941
ACCESSION NUMBER: 0001209191-16-109439
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160316
FILED AS OF DATE: 20160318
DATE AS OF CHANGE: 20160318
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 161515914
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-03-16
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2016-03-16
4
M
0
5130
35.35
A
270414
D
Common Stock
2016-03-16
4
S
0
1300
78.07
D
269114
D
Common Stock
2016-03-16
4
S
0
1533
79.00
D
267581
D
Common Stock
2016-03-16
4
S
0
1197
79.98
D
266384
D
Common Stock
2016-03-16
4
S
0
300
81.00
D
266084
D
Common Stock
2016-03-16
4
S
0
600
82.27
D
265484
D
Common Stock
2016-03-16
4
S
0
200
82.98
D
265284
D
Common Stock
13286
I
401k
Common Stock
122700
I
Common Stock Held In Trust
Stock Option (Right to Buy)
35.35
2016-03-16
4
M
0
5130
0.00
D
2016-07-19
Common Stock
5130
82090
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $78.07 (range $77.71 to $78.62).
Open market sales reported on this line occurred at a weighted average price of $79.00 (range $78.73 to $79.45).
Open market sales reported on this line occurred at a weighted average price of $79.98 (range $79.74 to $80.31).
Open market sales reported on this line occurred at a weighted average price of $81.00 (range $80.92 to $81.12).
Open market sales reported on this line occurred at a weighted average price of $82.27 (range $81.94 to $82.79).
Fully vested.
Michael LaCascia, Attorney-In-Fact
2016-03-18